Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)
Recruiting · NCT05298722 · Registry updated 2025-04-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not applicable | 2025-04-02 | NCT05298722 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Ghent | 163 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Alma Eeklo | Eeklo | Belgium | 1 |
| AZ Jan Palfijn Ghent | Ghent | Belgium | 1 |
| AZ Oudenaarde | Oudenaarde | Belgium | 2 |
| AZ Sint Blasius Dendermonde | Dendermonde | Belgium | 1 |
| AZ Sint Lucs Ghent | Ghent | Belgium | 1 |
| AZ Vitaz Sint Niklaas - Lokeren | Sint-Niklaas | Belgium | 1 |
| Ghent University Hospital | Ghent | Belgium | 6 |
| ZorgSaam ZH DeHonte Terneuzen | Terneuzen | Netherlands | 1 |